Circadian clock pathway genes associated with colorectal cancer risk and prognosis

[1]  Jeffrey E. Lee,et al.  Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival , 2018, International journal of cancer.

[2]  P. A. van den Brandt,et al.  Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology , 2017, Current Colorectal Cancer Reports.

[3]  S. Takenoshita,et al.  Expression of circadian clock genes in human colorectal adenoma and carcinoma , 2017, Oncology letters.

[4]  H. Nagase,et al.  Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer. , 2016, Bioscience trends.

[5]  Gang Ji,et al.  Genetic polymorphisms in circadian negative feedback regulation genes predict overall survival and response to chemotherapy in gastric cancer patients , 2016, Scientific Reports.

[6]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[7]  S. McGuire.  World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. , 2016, Advances in nutrition.

[8]  L. Hou,et al.  A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1 , 2015, Human Genetics.

[9]  Xiangyi Zheng,et al.  A meta-analysis including dose-response relationship between night shift work and the risk of colorectal cancer , 2015, Oncotarget.

[10]  Suo-zhu Sun,et al.  RORα inhibits adipocyte-conditioned medium-induced colorectal cancer cell proliferation and migration and chick embryo chorioallantoic membrane angiopoiesis. , 2015, American journal of physiology. Cell physiology.

[11]  H. Brauch,et al.  Polymorphisms in circadian genes, night work and breast cancer: Results from the GENICA study , 2014, Chronobiology international.

[12]  Jennifer R. Rider,et al.  Circadian clock genes and risk of fatal prostate cancer , 2014, Cancer Causes & Control.

[13]  P. Guénel,et al.  Breast cancer risk, nightwork, and circadian clock gene polymorphisms. , 2014, Endocrine-related cancer.

[14]  Zhi-gang Zhang,et al.  Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma , 2014, Tumor Biology.

[15]  A. Vaiopoulou,et al.  Association of the clock genes polymorphisms with colorectal cancer susceptibility , 2013, Journal of surgical oncology.

[16]  A. Brooks-Wilson,et al.  Shift work, circadian gene variants and risk of breast cancer. , 2013, Cancer epidemiology.

[17]  Helge Kjuus,et al.  Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts , 2013, Breast Cancer Research.

[18]  P. Kraft,et al.  Circadian genes and breast cancer susceptibility in rotating shift workers , 2012, International journal of cancer.

[19]  A. Antonacopoulou,et al.  Altered expression of NFY-C and RORA in colorectal adenocarcinomas. , 2012, Acta histochemica.

[20]  R. Reiter,et al.  Melatonin membrane receptors in peripheral tissues: Distribution and functions , 2012, Molecular and Cellular Endocrinology.

[21]  G. Xiong,et al.  RORα suppresses breast tumor invasion by inducing SEMA3F expression. , 2012, Cancer research.

[22]  D. Rozman,et al.  Circadian regulation of the hepatic endobiotic and xenobitoic detoxification pathways: the time matters. , 2012, Chemical research in toxicology.

[23]  D. Hwang,et al.  DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis. , 2011, Molecular cell.

[24]  Lin Yuan,et al.  Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night , 2011, Journal of pineal research.

[25]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[26]  D. Weaver,et al.  Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes , 2011, Aging.

[27]  R. Stevens,et al.  Shift work and cancer - considerations on rationale, mechanisms, and epidemiology. , 2010, Scandinavian journal of work, environment & health.

[28]  M. Rosenfeld,et al.  RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. , 2010, Molecular cell.

[29]  L. Liang,et al.  Mapping complex disease traits with global gene expression , 2009, Nature Reviews Genetics.

[30]  H. Stefánsson,et al.  Genetics of gene expression and its effect on disease , 2008, Nature.

[31]  K. Yu,et al.  Variants in circadian genes and prostate cancer risk: a population-based study in China , 2007, Prostate Cancer and Prostatic Diseases.

[32]  J. Mariani,et al.  The “CholesteROR” Protective Pathway in the Vascular System , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[34]  Steven M. Reppert,et al.  Posttranslational Mechanisms Regulate the Mammalian Circadian Clock , 2001, Cell.

[35]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[36]  Jennifer R. Rider,et al.  Circadian clock genes and risk of fatal prostate cancer , 2014, Cancer Causes & Control.

[37]  J. Olson,et al.  Circadian pathway genes in relation to glioma risk and outcome , 2013, Cancer Causes & Control.

[38]  M. Antoch,et al.  The role of mammalian circadian proteins in normal physiology and genotoxic stress responses. , 2007, Current topics in developmental biology.

[39]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.